Tags |
|
|
Links |
|
|
Advice You - Salespeople: Read This Article Later!
I was just asking myself what advice I’d give you, today, to
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
help you to increase sales.
We could cover ways to open sa
We could cover ways to open sa
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
les calls, describe your products and services, closing tech
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
iques, the best methods for delaying and answering objection
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
s and the like.
And it hit me.
Instead of reading this art
And it hit me.
Instead of reading this art
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
cle, right now, which is ABOUT selling, you should actually
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
BE selling, without delay.
In other words, if I could persu
In other words, if I could persu
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ade you to drop everything, and to make that phone call, or
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
o write that proposal, or to get into the car and pitch some
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
one, in the flesh, well, that would make me very successful,
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
and you, too.
What have you been putting off doing?
I have
What have you been putting off doing?
I have
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
a lead or two that I generated that I need to call back and
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
set appointments with.
From a strict selling standpoint, t
From a strict selling standpoint, t
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
at’s exactly what I need to do, right now.
After doing it,
After doing it,
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
I’ll feel better and I’ll be on my way to more sales. So, mo
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
entarily, that’s precisely what’s going to happen.
Prime se
Prime se
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
lling hours are precious and few. Take advantage of them, ri
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ght away.
And put off other things, though they’re importan
And put off other things, though they’re importan
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
, like planning and list development, and continuing educati
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
on, until later.
There’s always time to read.
And to write
There’s always time to read.
And to write
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/37571/adviceyou-Salespeople-Read-This-Article-Later.html">Salespeople: Read This Article Later!</a>
BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/37571/adviceyou-Salespeople-Read-This-Article-Later.html]Salespeople: Read This Article Later![/url]
Related Articles:
The Top Six Reasons to Buy Rather Than Build an Inventory Management Solution
Small Business Marketing - Should You Toot Your Own Horn?
Creating a Mini Lead Nurturing System in Less than Thirty Six Hours
Bookmark it:
|